Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Proton radiotherapy]

T Okumura1, H Tsuji, H Tsujii

  • 1Proton Medical Research Center University of Tsukuba, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biosynthetic transport of a major lysosomal membrane glycoprotein, lamp-1: convergence of biosynthetic and endocytic pathways occurs at three distinctive points.

Experimental cell research·1995
Same author

Expression of the Bombyx mori beta-tubulin-encoding gene in testis.

Gene·1995
Same author

[Progress of chronic hepatitis C to liver cirrhosis--comparison with chronic hepatitis B].

Nihon rinsho. Japanese journal of clinical medicine·1995
Same author

The human gene encoding the largest subunit of RNA polymerase II.

Gene·1995
Same author

Tumor cell attachment to laminin promotes degradation of the extracellular matrix and cell migration in high-metastatic clone cells of RCT sarcoma in vitro.

Japanese journal of cancer research : Gann·1995
Same author

Micro-assay to measure the allergenicity of a Kunitz-type soybean trypsin inhibitor toward Balb/c mice by using RBL-2H3 cells.

Bioscience, biotechnology, and biochemistry·1995
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Proton radiotherapy offers superior dose distribution for cancer treatment. Ongoing research and technological advancements are expanding its applications for various tumors, positioning it as a key future cancer therapy.

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Particle Therapy

Context:

  • Proton radiotherapy has demonstrated significant clinical value for over thirty years.
  • Established success in treating specific cancers like uveal melanoma and skull base sarcomas.
  • Technological advancements now enable treatment of deeper-seated tumors.

Purpose:

  • To review the established clinical benefits and current technological advancements in proton radiotherapy.
  • To highlight the need for further research into new tumor types.
  • To project the future role of proton therapy in oncology.

Summary:

  • Protons provide ideal dose distribution for radiotherapy, with proven clinical success in specific cancers.
  • Modern accelerators and gantry systems facilitate treatment of deep-seated tumors.

Related Experiment Videos

  • Further evaluation is needed for new tumor indications, with increasing global facility growth.

    • Impact:

    • Proton radiotherapy is a recognized and evolving cancer treatment modality.
    • Technological progress is broadening the scope of treatable tumors.
    • Expected to become increasingly important in future cancer care strategies.